2[20]Lincoff AM, Harrington RA, Califf RM, et al. Management of patients with acute coronary syndromes in the United States by platelet glycoprotein Ⅱ b/Ⅲ a inhibition. Insights from the platelet glycoprotein Ⅱ b/Ⅲ a in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation,2000,102(10):1093～ 1100.
3[21]Yusuf S, Zhao F, Mehta SR. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST- segment elevation.N Engl J Med,2001,345(7): 494～ 502.
4[22]Anonymous. Randomised thai of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS- 1. First International Study of Infarct Survival Collaborative Group.Lancet,1986,2:57～ 66.
5[23]Anonymous. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo- controlled intemational trial. The MIAMI Trial Research Group. Eur Heart J,1985,6(3):199～ 226.
6[24]Hjalmarson A,Elmfeldt D,Herlitz J,et al. Effect on mortality of metoprolol in acute myocardial infarction. A double- blind randomised trial.Lancet,1981,2:823～ 827.
7[1]Aronow WS. New coronary events at four- year follow- up in elderly patients with recognized or unrecognized myocardial infarction. Am J Cardiol,1989,63(9):621～ 622.
8[3]White HD, Barbash GI, Califf RM, et al. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO- I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation 1996;94(8): 1826～ 1833.
9[5]Thiemann DR, Coresh J, Schulman SP, et al. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation,2000,101(19):2239～ 2246.
10[6]Soumerai SB, McLaughlin T J, Ross- Degnan D, et al. Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: cause for concern in the old- old. Arch Intern Med,2002,162(5):561～ 568.
